In fact, melanoma is one of the most common cancers in people below the age of 30
GLP-1 medications slow digestion, increase feelings of fullness, reduce hunger signals, and stabilize blood sugar levels, helping patients eat less naturally and maintain consistent, long-term weight loss
To solve the Price-Safety Trap, we developed a unique scoring methodology called the Price & Trust Transparency Score
Cai X, Li J, Wang M, et al
Unlike semaglutide (Ozempic/Wegovy), which targets a single receptor (GLP-1), or tirzepatide (Mounjaro/Zepbound), a dual agonist for GLP-1 and GIP receptors, retatrutide goes one step further and acts as a triple agonist targeting GLP-1, GIP and glucagon receptors